Location New York, New York, United States Regions Greater New York Area, East Coast, Northeastern US Gender Male
LinkedIn View on LinkedIn
Mark has led and supported teams launching transformative new innovations globally at Molecular Stagings and 454 Life Sciences. In 2004, he led the development team at 454 Life Sciences that launched the GS 20, the first of the NGS (Next Generation Sequencing) systems, which revolutionized the world of DNA sequencing. He was part of the development
teams that launched the GS FLX, the GS FLX+, and the GS Junior, the first of the benchtop sequencers. Mark has experience leading a development team consisting of subteams in hardware, software, informatics, reagents, marketing, and customer support.
Mark received his Ph.D. in Biochemistry from the University of Rochester and his B.S. in Biology from the University of Buffalo.
